Gener8 Acquires Symbient Product Development
February 25, 2020
Gener8 LLC, a portfolio company of Sverica Capital Management, has acquired Symbient Product Development, a Carlsbad, California-based designer and low-to-medium volume manufacturer of polymer life-sciences consumables. The deal expands Gener8's capabilities beyond advanced instrumentation to provide turnkey instrument-and-consumable solutions for point-of-care diagnostics and drug delivery markets.
- Buyers
- Gener8 LLC, Sverica Capital Management LP
- Targets
- Symbient Product Development, LLC
- Platforms
- Gener8 LLC
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Currier Plastics Acquires Sage Product Development
August 7, 2026
Medical Devices
Currier Plastics, a life sciences contract development and manufacturing provider, completed its strategic acquisition of Sage Product Development. Sage is an engineering, design, and development provider that helps medical device companies take products from concept to commercialization, including contract manufacturing support.
-
GenNx360 Capital Partners Acquires Majority Stake in Tensentric
March 18, 2022
Medical Devices
GenNx360 Capital Partners has made a majority investment in Tensentric, a Boulder-based provider of design, engineering, prototyping and assembly services for medical technology, IVD and life-sciences companies. The investment will support Tensentric's next phase of growth and enable the company to scale its services capabilities through organic and inorganic initiatives.
-
Gener8 Acquires The RND Group
December 9, 2021
Medical Devices
Gener8 LLC, a portfolio company of Sverica Capital Management, has completed the acquisition of The RND Group, an Indianapolis-based provider of software development for medical device and life sciences products. The acquisition adds full-lifecycle regulated software capabilities — including cloud solutions, verification & validation, quality system compliance, and LIS/EHR integration — to Gener8's existing instrument, consumable and firmware offerings to extend services off-instrument and accelerate customer development timelines.
-
Salona Global Medical Device Corp. Acquires Simbex, LLC
September 30, 2021
Medical Devices
Salona Global Medical Device Corporation (SGMD) acquired Simbex, LLC, an IP-driven medical device design and product company that generated approximately US$8.0 million in 2020 revenue. The acquisition is intended to expand SGMD’s recovery-medicine product portfolio, leverage manufacturing capabilities, and increase annualized run-rate revenues to over $24 million.
-
Summa Equity Acquires Majority Stake in Sengenics
October 14, 2020
Biotechnology
Summa Equity Fund II has acquired a majority stake in Sengenics, a functional proteomics company that commercialises the KREX technology for full‑length, correctly folded protein production and autoantibody detection. The investment will support Sengenics' product development, global expansion and accelerated commercial adoption across pharma, academic research and diagnostics.
-
Servier Acquires Symphogen A/S from Novo Holdings and Other Owners
April 3, 2020
Biotechnology
Servier has acquired 100% of the share capital of Symphogen A/S from Novo Holdings and the remaining owners, taking ownership of the Danish therapeutic antibody discovery and early biologics development company. The deal brings Symphogen’s antibody discovery platform and CMC biologics development capabilities into Servier’s oncology and immuno-oncology R&D efforts to strengthen its biologics pipeline and development capacity.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.